Chargement en cours...

Newer agents in antiplatelet therapy: a review

Antiplatelet therapy remains the mainstay in preventing aberrant platelet activation in pathophysiological conditions such as myocardial infarction, ischemia, and stroke. Although there has been significant advancement in antiplatelet therapeutic approaches, aspirin still remains the gold standard t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yeung, Jennifer, Holinstat, Michael
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2012
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3393068/
https://ncbi.nlm.nih.gov/pubmed/22792011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S25421
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!